Abstract
Purpose
This study presents 3-year postoperative outcomes of posterior spinal correction and fusion of a patient diagnosed with late-onset Pompe disease (PD) for his progressive scoliosis.
Methods
The patient was diagnosed for PD during his infancy. Enzyme replacement therapy (ERT) was initiated at the age of 13. First office visit for his spinal deformity was at the age of 15, and 40°, 34°, 6° spinal curvatures were seen in T6–L3, T1–6, and L3–S, respectively. Reduced pulmonary function, limited gait function and atrophied limb were documented. Initial brace treatment could not control curve progression; therefore, posterior spinal correction and fusion were performed at the age of 17.
Results
Immediate preoperative curves of 55°, 42° and 23° were corrected to 18°, 26° and 7° in T6–L2, T1–T6 and L2–S, respectively. Spinal fusion was performed from T3 to L4. The patient exhibited an excessively low pulmonary function preoperatively with a VC, FVC, and %VC of 1.45 L, 1.36 L, and 35 %, respectively. This has been managed with only moderate reductions despite reduced pulmonary function from PD throughout the operative period and at 3 years. At the final follow-up, VC, FVC and %VC were 1.33 L, 1.12 L and 28.5 %, respectively.
Conclusion
Posterior spinal correction and fusion adequately controlled spinal curvatures for 3 years after surgery. Additionally, pulmonary function was managed throughout the follow-up period. Despite ERT, skeletal muscle and pulmonary function can still be severely affected by PD. Spinal correction and fusion is a useful method for the management of spinal curvature and pulmonary function in patients with PD.
Similar content being viewed by others
References
Fukuda T, Ahearn M, Roberts A et al (2006) Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. Mol Ther 14:831–839. doi:10.1016/j.ymthe.2006.08.009
Byrne BJ, Falk DJ, Pacak CA et al (2011) Pompe disease gene therapy. Hum Mol Genet 20:R61–R68. doi:10.1093/hmg/ddr174
Roberts M, Kishnani PS, van der Ploeg AT et al (2011) The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe registry. Mol Genet Metab 104:574–582. doi:10.1016/j.ymgme.2011.08.011
Dasouki M, Jawdat O, Almadhoun O et al (2014) Pompe disease: literature review and case series. Neurol Clin 32:751–776. doi:10.1016/j.ncl.2014.04.010
Fukuda T, Roberts A, Ahearn M et al (2006) Autophagy and lysosomes in Pompe disease. Autophagy 2(4):318–320
Schüller A, Wenninger S, Strigl-Pill N, Schoser B (2012) Toward deconstructing the phenotype of late-onset Pompe disease. Am J Med Genet C Semin Med Genet 160C:80–88. doi:10.1002/ajmg.c.31322
Rowe DE, Bernstein SM, Riddick MF et al (1997) A meta-analysis of the efficacy of non-operative treatments for idiopathic scoliosis. J Bone Joint Surg Am 79:664–674
Haaker G, Forst J, Forst R, Fujak A (2014) Orthopedic management of patients with Pompe disease: a retrospective case series of 8 patients. Sci World J 2014:963861. doi:10.1155/2014/963861
Kishnani PS, Steiner RD, Bali D et al (2006) Pompe disease diagnosis and management guideline. Genet Med 8:267–288. doi:10.1097/01.gim.0000218152.87434.f3
Kono K, Asazuma T, Suzuki N, Ono T (2000) Body height correction in scoliosis patients for. J Orthop Surg 8:19–26
Acknowledgments
I would like to thank Dr. Warren Williams from the University of British Columbia and Ms. Hiroko Matsumoto from the Columbia University Medical Center for the support they have provided me in the production of this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author(s) of this publication serves as a consultant for Medtronic and Depuy Synthes. The author(s) also receives Grant/Research Support from Japan Spinal Deformity Institute. However, all aforementioned relationships are not related to the production of this paper.
Rights and permissions
About this article
Cite this article
Kawakami, K., Kawakami, N., Nohara, A. et al. Spinal fusion as a viable treatment option for scoliosis management in Pompe disease: a postoperative 3-year follow-up. Eur Spine J 25 (Suppl 1), 140–146 (2016). https://doi.org/10.1007/s00586-015-4249-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-015-4249-7